The Quality Lowdown: Warning Letters Suggest How The FDA Set Priorities During COVID-19
Executive Summary
Calvin Scott, Acella Pharmaceuticals, Soluciones Cosmeticas and TAKA USA warning letters highlight issues with quality units, process control and specifications.